Rob Stein
Stories
-
Health
FDA authorizes first Covid booster for children ages 5 to 11
The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.
-
Health
Biden marks 1 million deaths from COVID-19 in the United States
President Biden is honoring the loss of at least 1 million deaths from COVID-19 Thursday morning. The ceremony comes as part of an international summit on the pandemic that the White House is hosting.
-
National
Moderna asks FDA to authorize first COVID-19 vaccine for very young children
The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
-
Health
FDA considers a Pfizer booster and a Moderna vaccine for children
Pfizer has asked for authorization for the first booster for children 5 to 11 and Moderna is poised to ask for authorization for the first vaccine for children younger than 5.
-
National
The FDA may soon authorize a COVID booster for kids ages 5 to 11
Pfizer and BioNTech are poised to formally ask the Food and Drug Administration to authorize the first COVID booster shot for kids ages 5 to 11.
-
National
Moderna says its new 'bivalent' vaccine shows promise against COVID variants
The company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.
-
Health
U.S. life expectancy falls for 2nd year in a row
The pandemic drove U.S. life expectancy down again in 2021 even though life-saving vaccines were widely available.
-
National
Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines
Federal health officials are convening with outside advisers April 6 to talk about a vaccine plan, whether that's another booster in the fall, an omicron shot or one that targets more than one strain.
-
Health
Does it make sense for older people to get another booster against COVID-19?
With the FDA poised to OK another booster for people 50 and older, questions remain: Is the evidence strong enough to warrant a fourth shot, does the timing make sense, and will there be much demand?
-
Business
Moderna will ask the FDA to authorize its COVID-19 vaccine for children under 6
Moderna says its low-dose pediatric vaccine appears to be safe and provide protection for kids ages 6 months to 6 years, and it is asking the Food and Drug Administration for emergency authorization.